We are live on ! Find out more
CAPTRUST Financial Advisors

CAPTRUST Financial Advisors Portfolio holdings

AUM $57.3B
1-Year Est. Return 18.32%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+18.32%
3 Year Est. Return
+60%
5 Year Est. Return
+73.18%
10 Year Est. Return
+239.88%
AUM
$14.6B
AUM Growth
+$2.55B
Cap. Flow
+$1.54B
Cap. Flow %
10.53%
Top 10 Hldgs %
22.66%
Holding
5,268
New
426
Increased
2,142
Reduced
1,399
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 14.83%
2 Financials 8.43%
3 Healthcare 7.26%
4 Industrials 6.5%
5 Consumer Discretionary 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PVLA
3776
Palvella Therapeutics
PVLA
$2.03B
$4K ﹤0.01%
13
SHPWW
3777
DELISTED
Shapeways Holdings, Inc. Warrants
SHPWW
$4K ﹤0.01%
8,514
SHPW
3778
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$4K ﹤0.01%
125
+62
+98% +$2.91K
TARO
3779
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$4K ﹤0.01%
72
-1
-1% -$56
NTCO
3780
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$4K ﹤0.01%
480
SRT
3781
DELISTED
Startek Inc.
SRT
$4K ﹤0.01%
+860
New +$4.31K
PHUNW
3782
DELISTED
Phunware, Inc. Warrants
PHUNW
$4K ﹤0.01%
2,814
SCU
3783
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$4K ﹤0.01%
184
-42
-19% -$959
CANO
3784
DELISTED
Cano Health, Inc.
CANO
$4K ﹤0.01%
5
EMAN
3785
DELISTED
eMagin Corporation
EMAN
$4K ﹤0.01%
3,450
-200
-5% -$400
PRTK
3786
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4K ﹤0.01%
826
PLXP
3787
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$4K ﹤0.01%
550
AUY
3788
DELISTED
Yamana Gold, Inc.
AUY
$4K ﹤0.01%
850
COVAW
3789
DELISTED
COVA Acquisition Corp. Warrants to purchase Class A ordinary shares
COVAW
$4K ﹤0.01%
7,528
MIT.WS
3790
DELISTED
Mason Industrial Technology, Inc. Redeemable warrants, exercisable for one share of Class A common stock for $11.50 per share
MIT.WS
$4K ﹤0.01%
+6,360
New +$4.52K
ATHX
3791
DELISTED
Athersys, Inc. Common Stock
ATHX
$4K ﹤0.01%
180
+20
+13% +$574
ELMS
3792
DELISTED
Electric Last Mile Solutions, Inc. Class A Common stock
ELMS
$4K ﹤0.01%
607
VCRA
3793
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$4K ﹤0.01%
55
+5
+10% +$281
SRAX
3794
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$4K ﹤0.01%
1,000
CEI
3795
DELISTED
Camber Energy, Inc
CEI
$4K ﹤0.01%
+90
New +$5.79K
MRGO
3796
DELISTED
MARGO CARIBE INC
MRGO
$4K ﹤0.01%
275
NWBO
3797
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$4K ﹤0.01%
6,290
ADV icon
3798
Advantage Solutions
ADV
$504M
$3K ﹤0.01%
+17
New +$3.5K
AEVA
3799
Aeva Technologies
AEVA
$1.06B
$3K ﹤0.01%
81
-461
-85% -$19.4K
ALCO icon
3800
Alico
ALCO
$286M
$3K ﹤0.01%
92
-2
-2% -$71

Similar funds

CAPTRUST Financial Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, CAPTRUST Financial Advisors held 5,268 positions worth $14.6B, up 21% from $12B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

CAPTRUST Financial Advisors deployed $1.54B of net new capital in Q4 2021, opening 426 new positions and adding to 2,142 existing holdings. Its largest new stake was Crescent Energy: 320,682 shares worth $4.07M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Ciena, an estimated $25.1M trimmed.

  • CAPTRUST Financial Advisors's largest Q4 2021 buy was Crescent Energy: 320,682 shares worth $4.07M.
  • CAPTRUST Financial Advisors added most to Vanguard Mega Cap Growth ETF in Q4 2021, an estimated $193M increase.
  • CAPTRUST Financial Advisors's biggest Q4 2021 reduction was Ciena, cutting an estimated $25.1M.
  • CAPTRUST Financial Advisors fully exited iShares iBonds Dec 2021 Term Corporate ETF in Q4 2021, selling an estimated $9.71M.
  • CAPTRUST Financial Advisors's ten largest holdings make up 23% of its $14.6B portfolio in Q4 2021.
  • CAPTRUST Financial Advisors opened 426 new positions and closed 238 in Q4 2021.
  • CAPTRUST Financial Advisors's portfolio value rose 21% quarter-over-quarter to $14.6B.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.